The global medical landscape is shifting towards precision medicine. Globally, the demand for effective molecules with no/low toxicity is on the rise. KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). It is among the most promising peptides to treat skin regeneration and inflammatory disorders, such as eczema. According to a paper in the International Journal of Medical Sciences, KPV could change the treatment protocols for inflammation in several ways. Anti-Inflammatory Medicine is...










